Artemis Medicare Services Limited

NSEI:ARTEMISMED Stock Report

Market Cap: ₹39.9b

Artemis Medicare Services Management

Management criteria checks 2/4

Artemis Medicare Services' CEO is Devlina Chakravarty, appointed in Jan 2014, has a tenure of 10.67 years. total yearly compensation is ₹183.34M, comprised of 35.3% salary and 64.7% bonuses, including company stock and options. directly owns 2.14% of the company’s shares, worth ₹854.16M. The average tenure of the management team and the board of directors is 4.3 years and 6.9 years respectively.

Key information

Devlina Chakravarty

Chief executive officer

₹183.3m

Total compensation

CEO salary percentage35.3%
CEO tenure10.7yrs
CEO ownership2.1%
Management average tenure4.3yrs
Board average tenure6.9yrs

Recent management updates

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Artemis Medicare Services Limited's (NSE:ARTEMISMED) CEO For Now

Jul 18
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Artemis Medicare Services Limited's (NSE:ARTEMISMED) CEO For Now

Recent updates

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Artemis Medicare Services Limited's (NSE:ARTEMISMED) CEO For Now

Jul 18
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Artemis Medicare Services Limited's (NSE:ARTEMISMED) CEO For Now

Artemis Medicare Services Limited's (NSE:ARTEMISMED) P/E Is Still On The Mark Following 31% Share Price Bounce

Jul 16
Artemis Medicare Services Limited's (NSE:ARTEMISMED) P/E Is Still On The Mark Following 31% Share Price Bounce

After Leaping 27% Artemis Medicare Services Limited (NSE:ARTEMISMED) Shares Are Not Flying Under The Radar

Apr 13
After Leaping 27% Artemis Medicare Services Limited (NSE:ARTEMISMED) Shares Are Not Flying Under The Radar

Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet

Jun 14
Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet

Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet

Mar 15
Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet

Capital Allocation Trends At Artemis Medicare Services (NSE:ARTEMISMED) Aren't Ideal

Aug 31
Capital Allocation Trends At Artemis Medicare Services (NSE:ARTEMISMED) Aren't Ideal

Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?

Jul 30
Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?

Artemis Medicare Services (NSE:ARTEMISMED) Is Reinvesting At Lower Rates Of Return

May 13
Artemis Medicare Services (NSE:ARTEMISMED) Is Reinvesting At Lower Rates Of Return

Returns On Capital At Artemis Medicare Services (NSE:ARTEMISMED) Paint A Concerning Picture

Jan 11
Returns On Capital At Artemis Medicare Services (NSE:ARTEMISMED) Paint A Concerning Picture

Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet

Dec 10
Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet

There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital

Sep 11
There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital

Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet

Jul 01
Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet

There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital

May 11
There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital

We Think Artemis Medicare Services (NSE:ARTEMISMED) Is Taking Some Risk With Its Debt

Mar 16
We Think Artemis Medicare Services (NSE:ARTEMISMED) Is Taking Some Risk With Its Debt

Is Artemis Medicare Services (NSE:ARTEMISMED) Likely To Turn Things Around?

Jan 22
Is Artemis Medicare Services (NSE:ARTEMISMED) Likely To Turn Things Around?

Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?

Nov 13
Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?

Market Still Lacking Some Conviction On Artemis Medicare Services Limited (NSE:ARTEMISMED)

Jul 20
Market Still Lacking Some Conviction On Artemis Medicare Services Limited (NSE:ARTEMISMED)

CEO Compensation Analysis

How has Devlina Chakravarty's remuneration changed compared to Artemis Medicare Services's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

₹560m

Mar 31 2024₹183m₹65m

₹491m

Dec 31 2023n/an/a

₹456m

Sep 30 2023n/an/a

₹445m

Jun 30 2023n/an/a

₹400m

Mar 31 2023₹139m₹46m

₹386m

Dec 31 2022n/an/a

₹412m

Sep 30 2022n/an/a

₹373m

Jun 30 2022n/an/a

₹363m

Mar 31 2022₹49m₹46m

₹318m

Dec 31 2021n/an/a

₹313m

Sep 30 2021n/an/a

₹301m

Jun 30 2021n/an/a

₹221m

Mar 31 2021₹51m₹48m

₹65m

Dec 31 2020n/an/a

-₹19m

Sep 30 2020n/an/a

-₹16m

Jun 30 2020n/an/a

₹38m

Mar 31 2020₹52m₹48m

₹198m

Compensation vs Market: Devlina's total compensation ($USD2.19M) is above average for companies of similar size in the Indian market ($USD268.70K).

Compensation vs Earnings: Devlina's compensation has increased by more than 20% in the past year.


CEO

Devlina Chakravarty (56 yo)

10.7yrs

Tenure

₹183,337,000

Compensation

Dr. Devlina Chakravarty, M.D., DNB, DMRD, Radiolog,y serves as Chief Executive Officer at Artemis Medicare Services Limited and its Managing Director and Executive Director since February 2, 2015. Dr. Chak...


Leadership Team

NamePositionTenureCompensationOwnership
Devlina Chakravarty
CEO, MD & Executive Director10.7yrs₹183.34m2.14%
₹ 854.2m
Sanjiv Kothari
Chief Financial Officerno data₹8.63mno data
Poonam Makkar
Company Secretary & Compliance Officer1.8yrs₹4.24mno data
Ashutosh Kumar Jha
Chief-Strategyno datano datano data
Vivek Singh
Head of Legalno datano datano data
Saras Malik
Chief People Officer of Human Resources & Trainingno datano datano data
Manju Aggarwal
Chief Medical Services & Chairperson of Nephrology4.3yrsno datano data
Kapil Kumar
Chief Technology Officer- Medical Informaticsno datano datano data

4.3yrs

Average Tenure

Experienced Management: ARTEMISMED's management team is considered experienced (4.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Devlina Chakravarty
CEO, MD & Executive Director9.4yrs₹183.34m2.14%
₹ 854.2m
Onkar Kanwar
Non-Executive Non-Independent Chairman18yrs₹400.00k0.0036%
₹ 1.4m
Neeraj Kanwar
Non-Executive & Non-Independent Director16.7yrs₹480.00kno data
Pallavi Shroff
Independent Directorno datano datano data
Nirmal Ganguly
Non-Executive & Non-Independent Director10.6yrs₹2.92mno data
Akshay Kumar Chudasama
Independent Directorno data₹180.00kno data
Deepa Wadhwa
Non-Executive Independent Woman Director4.3yrs₹540.00kno data
Sunil Tandon
Non-Executive Independent Director3.3yrs₹520.00kno data
Sanjib Sen
Independent Director4.1yrs₹460.00kno data
Shalini Chand
Non-Executive & Non-Independent Director17.7yrs₹480.00kno data

6.9yrs

Average Tenure

62.5yo

Average Age

Experienced Board: ARTEMISMED's board of directors are considered experienced (6.9 years average tenure).